Neurovia Overview

  • Founded
  • 2013

Founded
  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Neurovia General Information

Description

Developer of therapies designed to offer treatment for neurological disorders. The company's therapies have developed a selective thyromimetic agent for the treatment of X-linked adrenoleukodystrophy, enabling X-ALD patients to get treatment for their rare genetic disease.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1700 Owens Street
  • Suite 525
  • San Francisco, CA 94158
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurovia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Nov-2018 000.00 Completed Out of Business
1. Early Stage VC (Series A) 25-May-2017 000.00 000.00 000.00 Completed Clinical Trials - Phase 1
To view Neurovia’s complete valuation and funding history, request access »

Neurovia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view Neurovia’s complete cap table history, request access »

Neurovia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapies designed to offer treatment for neurological disorders. The company's therapies have developed a
Biotechnology
San Francisco, CA
000.00
00000000 00 000.00

0000 0

enderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
0000 000000000
San Diego, CA
00 As of 0000
00000
00000000 00000

000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000 000000000
Burlingame, CA
00 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurovia Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
aTyr Pharma Formerly VC-backed San Diego, CA 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed San Diego, CA 00 00000 000000 - 000 00000
000000000 000000 Venture Capital-Backed Boston, MA 00 00000 0000000000 0 00000
000000000 Formerly VC-backed South San Francisco, CA 00 000.00 00000000 000.00
You’re viewing 5 of 23 competitors. Get the full list »